SCHEMBL7367582

SCHEMBL7367582

CCC(CSc1ccccc1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 4/20 0.51
▸ MTNR1B P49286 4/20 0.51
▸ MMP2 P08253 3/20 0.51
▸ MMP3 P08254 3/20 0.51
▸ MMP9 P14780 3/20 0.51
▸ MMP13 P45452 2/20 0.51
▸ MMP1 P03956 1/20 0.51
▸ MMP8 P22894 1/20 0.51
▸ MAOA P21397 1/20 0.48
▸ MAOB P27338 1/20 0.48
▸ FFAR1 O14842 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.42
▸ EGFR P00533 1/20 0.41
▸ KIF11 P52732 1/20 0.41
▸ MAPK1 P28482 1/20 0.40
▸ PPARG P37231 1/20 0.40
▸ TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23190984 0.88 MMP2 (0.56) MTNR1AMTNR1BMMP2MMP3MMP9
SCHEMBL28932705 0.84 MMP2 (0.55) MMP2MMP3MMP9MMP13MMP1
SCHEMBL7870421 0.80 MMP2 (0.50) MTNR1AMTNR1BMMP2MMP3MMP9
SCHEMBL13535268 0.77 MTNR1A (0.48) MTNR1AMTNR1BMMP2MMP3MMP9
SCHEMBL6896649 0.77 MTNR1A (0.51) MTNR1AMTNR1BMMP2MMP3MMP9
SCHEMBL6896645 0.77 MTNR1A (0.51) MTNR1AMTNR1BMMP2MMP3MMP9
SCHEMBL7368245 0.77 MTNR1A (0.59) MTNR1AMTNR1BMMP2MMP3MMP9
SCHEMBL8500821 0.75 CYP1A2 (0.53) CYP1A2ALDH1A1PPARG
SCHEMBL8500824 0.75 CYP1A2 (0.53) CYP1A2ALDH1A1PPARG
SCHEMBL5695682 0.75 TSHR (0.46) CYP1A2MEN1KMT2AALDH1A1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0790974-A1 SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS Bayer Corporation (US) 1997-08-27 — — EP claimed
WO-1996015096-A1 SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS BAYER CORPORATION (US) 1996-05-23 — — WO claimed
Send feedback